BAX and lung cancer: Thus, treatment of these lung cancer cells with GSPs can alter the protein levels of key members of the Bcl-2 family in a manner that favors an increase in the ratio of Bax: Bcl-2, which may contribute to the susceptibility of cancer cells to GSP-induced apoptosis [15].